Viewing Study NCT00005593


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2025-12-25 @ 11:21 PM
Study NCT ID: NCT00005593
Status: COMPLETED
Last Update Posted: 2010-06-11
First Post: 2000-05-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
Sponsor: Case Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CWRU1998
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Brenda W. Cooper, MD
Old Organization: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Collaborators

Collaborators

Name Class View
None NIH View